Acetic Acid — predicted protein targets

Known targets — ChEMBL curated mechanism

ADRA2A ADRA2B ADRA2C ADRB2 AGTR1 AVPR1A AVPR1B AVPR2 BDKRB2 CALCR CHRNA3 CHRNB4 ESR1 ESR2 GHSR GNRHR GSC1 HSPA8 MALT1 MC1R MC4R NOS1 NOS2 NOS3 OPRK1 OXTR RAMP1 RAMP2 RAMP3 SCN5A SSTR1 SSTR2 SSTR3 SSTR4 SSTR5 dacA dacB dacC folP ftsI mrcA mrcB mrdA rplA rplB rplC rplD rplE rplF rplJ rplK rplL rplM rplN rplO rplP rplQ rplR rplS rplT rplU rplV rplW rplX rplY rpmA rpmB rpmC rpmD rpmE rpmF rpmG rpmH rpmI rpmJ rpsA rpsB rpsC rpsD rpsE rpsF rpsG rpsH rpsI rpsJ rpsK rpsL rpsM rpsN rpsO rpsP rpsQ rpsR rpsS rpsT rpsU ykgM ykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

	gene	UniProt	supporting neighbours	confidence
▸	LCK	P06239	10/20	0.62

▸	SRC	P12931	10/20	0.62

▸	TEK	Q02763	10/20	0.62

▸	KDR	P35968	5/20	0.62

▸	IGF1R	P08069	10/20	0.59

▸	EGFR	P00533	9/20	0.59

▸	ERBB2	P04626	9/20	0.59

▸	ERBB3	P21860	9/20	0.59

▸	ERBB4	Q15303	9/20	0.59

▸	BTK	Q06187	1/20	0.56

▸	LIMK1	P53667	1/20	0.52

▸	LIMK2	P53671	1/20	0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
Acetic Acid SCHEMBL6430995	1.00	LCK (0.62)	LCKSRCTEKKDRIGF1R
SCHEMBL6433833	0.96	LCK (0.65)	LCKSRCTEKKDRIGF1R
SCHEMBL6433836	0.96	LCK (0.65)	LCKSRCTEKKDRIGF1R
Acetic Acid SCHEMBL7046447	0.92	LCK (0.54)	LCKSRCTEKKDRIGF1R
SCHEMBL5800665	0.91	IGF1R (0.63)	LCKSRCTEKKDRIGF1R
SCHEMBL6430355	0.91	LCK (0.71)	LCKSRCTEKKDRIGF1R
SCHEMBL6430359	0.91	LCK (0.71)	LCKSRCTEKKDRIGF1R
Acetic Acid SCHEMBL4828171	0.91	LCK (0.61)	LCKSRCTEKKDRIGF1R
Acetic Acid SCHEMBL7044708	0.91	EGFR (0.54)	LCKSRCTEKKDRIGF1R
SCHEMBL6430787	0.91	LCK (0.70)	LCKSRCTEKKDRIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-6921763-B2	Pyrazolopyrimidines as therapeutic agents	ABBOTT LABORATORIES (US)	2005-07-26	—	—	US	disclosed
US-20050008640-A1	Method of treating transplant rejection	ABBOTT LABORATORIES	2005-01-13	—	—	US	disclosed
US-6660744-B1	Kinase inhibitors	ABBOTT GMBH & CO. KG (DE)	2003-12-09	—	—	US	disclosed
EP-1212327-B1	PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS	BASF AG (DE)	2003-08-20	—	—	EP	disclosed
US-20020156081-A1	Pyrazolopyrimidines as therapeutic agents	ABBOTT LABORATORIES (US)	2002-10-24	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20050008640-A1	Method of treating transplant rejection	LCK, ZAP70, FYN	LCK 1/4885SRC 46/4885TEK 1465/4885
US-20020156081-A1	Pyrazolopyrimidines as therapeutic agents	DPYD, CYP2D6, UGT1A1	LCK 1011/4885SRC 1834/4885TEK 1657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.